Video

Recent Data for PARP Inhibitors in Recurrent Ovarian Cancer

A detailed discussion focused on recent data on PARP inhibitors in the recurrent ovarian cancer setting.

Related Videos
Bradley McGregor, MD, discusses findings from a phase 1b study of abemaciclib  in clear cell renal cell carcinoma.
5 KOLs are featured in this panel.
5 KOLs are featured in this panel.
4 KOLs are featured in this series
4 KOLs are featured in this series
4 KOLs are featured in this series
4 KOLs are featured in this series
A panel of 5 experts on breast cancer
A panel of 5 experts on breast cancer
5 KOLs are featured in this peer exchange